DMAC

DiaMedica Therapeutics Inc.

Insider Trades

NameValueActionPriceCurrent Price
Stahlberg Jan10 Percent Owner
$627k73.1k shares
BuyNov 25, 2025
$8.57
--
Stahlberg Jan10 Percent Owner
$318k40.3k shares
BuyNov 24, 2025
$7.89
--
Stahlberg Jan10 Percent Owner
$1.5M208.9k shares
BuyNov 21, 2025
$7.41
--
Stahlberg Jan10 Percent Owner
$951k128.4k shares
BuyNov 20, 2025
$7.41
--
Stahlberg Jan10 Percent Owner
$1.7M240.4k shares
BuyNov 19, 2025
$7.21
--
Stahlberg Jan10 Percent Owner
$1.2M182.9k shares
BuyNov 18, 2025
$6.75
--

News

businesswire.comDiaMedica Receives FDA Feedback on DM199 Preeclampsia Nonclinical Programbusinesswire.comJun 16businesswire.comDiaMedica Therapeutics to Present at the Jefferies Global Healthcare Conference 2026businesswire.comMay 27businesswire.comDiaMedica Therapeutics Announces 75% Enrollment Milestone in ReMEDy2 Phase 2/3 Acute Ischemic Stroke Trialbusinesswire.comMay 20businesswire.comDiaMedica Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conferencebusinesswire.comMay 12seekingalpha.comDiaMedica Therapeutics Inc. (DMAC) Q1 2026 Earnings Call Transcriptseekingalpha.comMay 7